CTU、增强MRI和CEUS在肾占位病变定性诊断中准确率的多维度分析

吴林杰 ,  于营 ,  白小杰 ,  戚子昊 ,  郑航 ,  郭中强

现代泌尿外科杂志 ›› 2025, Vol. 30 ›› Issue (1) : 48 -52.

PDF (950KB)
现代泌尿外科杂志 ›› 2025, Vol. 30 ›› Issue (1) : 48 -52. DOI: 10.3969/j.issn.1009-8291.2025.01.010
临床研究

CTU、增强MRI和CEUS在肾占位病变定性诊断中准确率的多维度分析

作者信息 +

Multidimensional analysis of accuracy of CTU, contrast-enhanced MRI and CEUS in qualitative diagnosis of renal space-occupying lesions

Author information +
文章历史 +
PDF (972K)

摘要

目的 多维度比较分析计算机体层成像尿路造影(CTU)、增强磁共振成像(MRI)及超声造影(CEUS)在肾占位性病变中定性诊断的准确率。方法 回顾性分析2019年1月-2024年5月武汉大学中南医院泌尿外科经手术病理证实的542例肾占位性病变患者的资料,结合患者临床及病理资料对其CTU、增强MRI及CEUS的检查结果进行分层多维度对比分析。结果 3项检查诊断肾占位性病变的准确率分别为CTU 84.50%、增强MRI 83.14%、CEUS 86.14%。同时行3项检查的161例患者中,CEUS对肾占位性病变定性诊断的准确率显著优于CTU(84.16% vs. 77.02%,P=0.018),而CTU或CEUS与增强MRI(79.81%)间定性诊断准确率的差异无统计学意义(P>0.05)。分层分析发现,对于≤4 cm肾占位性病变的定性诊断,CEUS与CTU的准确率均为79.55%、增强MRI为76.14%,差异无统计学意义(P>0.05);对>4 cm肾占位性病变的定性诊断,CEUS准确率为89.73%、增强MRI为84.25%、CTU为73.97%,CEUS和增强MRI的准确率明显优于CTU(P<0.05);对于透明细胞癌及良性肾占位的定性诊断,3项检查准确率之间的差异无统计学意义(P>0.05);CEUS对于非透明细胞癌定性诊断的准确率为83.87%、增强MRI为74.19%、CTU为56.45%,增强MRI和CEUS的诊断准确率显著大于CTU(P<0.05)。结论 3项检查方法对于肾占位性病变的诊断均具有重要的临床价值,临床上应根据具体情况选择合适的影像学检查方法。CEUS和增强MRI对于肾占位性病变定性诊断的准确率高于CTU,特别是在诊断直径较大的肾占位性病变及非透明细胞癌时。

Abstract

Objective To compare the diagnostic accuracy of three imaging modalities, including CT urography (CTU), contrast-enhanced MRI (CE-MRI), and contrast-enhanced ultrasound (CEUS) in the qualitative diagnosis of renal space-occupying lesions. Methods A retrospective analysis was performed on 542 patients with renal lesions confirmed by surgical pathology in our hospital during Jan. 2019 and May 2024. The diagnostic results of CTU, CE-MRI and CEUS were compared and analyzed based on the patients' clinical and pathological data. Results The diagnostic accuracy rate of CTU, CE-MRI and CEUS were 84.50%, 83.14% and 86.14%, respectively. For the 161 patients who underwent all three examinations, CEUS was significantly more accurate than CTU (84.16% vs. 77.02%, P=0.018), while there was no significant difference between CTU or CEUS and CE-MRI (79.81%) (P>0.05). Further analysis found that for lesions ≤4 cm, the accuracy of the three examinations was as follows: CEUS=CTU 79.55%, CE-MRI 76.14%, with no significant difference (P>0.05). However, for lesions >4 cm, CEUS ranked the first, followed by CE-MRI and CTU (89.73% vs. 84.25% vs. 73.97%), and CEUS and CE-MRI were better than CTU (P<0.05). Additionally, for the diagnosis of clear cell renal carcinoma and benign renal space-occupying lesions, there was no statistically significant difference among the three imaging modalities (P>0.05), while for the qualitative diagnosis of non-clear cell renal carcinoma, CEUS ranked the first, followed by CE-MRI and CTU (83.87% vs. 74.19% vs. 56.45%), and CE-MRI and CEUS were better than CTU (P<0.05). Conclusion All of them have important diagnostic value, and the appropriate selection should be based on patients' specific conditions. CEUS and CE-MRI are more accurate in the qualitative diagnosis of renal space-occupying lesions than CTU, especially for large lesions and non-clear cell carcinoma.

关键词

计算机体层成像尿路造影 / 增强磁共振成像 / 超声造影 / 肾占位性病变 / 定性诊断

Key words

computed tomography urography / magnetic resonance imaging / contrast-enhanced ultrasound / renal space-occupying lesions / qualitative diagnosis

引用本文

引用格式 ▾
吴林杰,于营,白小杰,戚子昊,郑航,郭中强. CTU、增强MRI和CEUS在肾占位病变定性诊断中准确率的多维度分析[J]. 现代泌尿外科杂志, 2025, 30(1): 48-52 DOI:10.3969/j.issn.1009-8291.2025.01.010

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

WEIS P, XU CL, ZHANG Q, et al. Contrast-enhanced ultrasound for differentiating benign from malignant solid small renal masses: comparison with contrast-enhanced CT [J]. Abdom Radiol (NY), 2017, 42(8): 2135-2145.

[2]

杜涛明, 唐烨真. CTA及CTU联合成像在肾癌术前诊断中的价值[J]. 现代临床医学, 2018, 44(6): 441-442, 445.

[3]

康素海, 叶慧义. MRI、B超及超声造影诊断小肾肿瘤的现状与进展[J]. 中国医学影像学杂志, 2016, 24(5): 396-400.

[4]

柴学云, 霍学军, 李娟. 超声造影联合增强CT在肾占位性病变中的应用价值[J]. 中国CT和MRI杂志, 2022, 20(4): 118-120, 129.

[5]

JAMET A, CARAMELLA C, GUIDA A, et al. Effect of immunotherapy (IO) on primary renal tumor in metastatic renal cell cancer (mRCC) [J]. J Clin Oncol, 2019, 37(7_suppl): 649.

[6]

丁作鹏, 胡春梅, 李光远. 常规超声联合超声造影在肾脏良恶性肿瘤中的鉴别价值[J]. 中国现代医学杂志, 2023, 33(18): 7-13.

[7]

邱志平, 杜明明, 李钟奇. CT三期动态增强扫描对早期肾透明细胞癌的诊断价值和准确性评价[J]. 现代医用影像学, 2022, 31(2): 281-283.

[8]

唐昌会. 64层螺旋CT造影在泌尿系统疾病诊断中应用[J]. 医学理论与实践, 2011, 24(9): 1007-1008.

[9]

韩超, 韩东明. 肾脏囊性占位病变CT及MRI表现与Bosniak分级对比[J]. 中国社区医师, 2015, 31(10): 96, 98.

[10]

AGGARWAL A, GOSWAMI S, DAS CJ. Contrast-enhanced ultrasound of the kidneys: principles and potential applications [J]. Abdom Radiol (NY), 2022, 47(4): 1369-1384.

[11]

LIU Q, GONG H, CHEN Q, et al. Clinical application value of contrast-enhanced ultrasound in the diagnosis of renal space-occupying lesions [J]. Int J Nephrol Renovasc Dis, 2023, 16: 253-259.

[12]

OLSON MC, ABEL EJ, MANKOWSKI GETTLE L. Contrast-enhanced ultrasound in renal imaging and intervention [J]. Curr Urol Rep, 2019, 20(11): 73.

AI Summary AI Mindmap
PDF (950KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉